1 |
Liu, L. F., Desai, S. D., Li, T. K., Mao, Y., Sun, M. and Sim, S. P. : Mechanism of action of camptothecin. Ann. N. Y. Acad. Sci. 922, 1 (2000)
|
2 |
Yamashita, Y, Kawada, S., Fujii, N. and Nakano, H. : Induction of mammalian DNA topoisomerase I and II mediated DNA cleavage by saintopin, a new antitumor agent from fungus. Biochemistry 30, 5838 (1991)
DOI
ScienceOn
|
3 |
Li, G., Xu, M. L., Lee, C. S., Woo, M. H., Chang, H. W. and Son, J. K. : Cytotoxicity and DNA topoisomerases inhibitory activity of constituents from the sclerotium of Poria cocos. Arch. Pharm. Res. 27, 829 (2004)
DOI
ScienceOn
|
4 |
Yasukawa, K., Kaminaga, T., Kitanaka, S., Tai, T., Nunoura, Y., Natori, S. and Takido, M. : 3 beta-p-hydroxybenzoyldehydrotumulosic acid from Poria cocos, and its anti-inflammatory effect. Phytochemistry 48, 1357 (1998)
DOI
ScienceOn
|
5 |
Carey, J. F., Schultz, S. J., Sisson, L., Fazzio, T. G. and Champoux, J. J. : DNA relaxation by human topoisomerase I occurs in the closed clamp conformation of the protein. Proc. Natl. Acad. Sci. 100, 5640 (2003)
|
6 |
Laco, G. S., Du, W., Kohlhagen, G., Sayer, J. M., Jerina, D. M., Burke, T. G., Curran, D. P. and Pommier, Y. : Analysis of human topoisomerase I inhibition and interaction with the cleavage site +1 deoxyguanosine, via in vitro experiments and molecular modeling studies. Bioorg. Med. Chem. 12, 5225 (2004)
DOI
ScienceOn
|
7 |
Ukiya, M., Akihisa, T., Tokuda, H., Hirano, M., Oshikubo, M., Nobukuni, Y, Kimura, Y., Tai, T., Kondo, S. and Nishino, H. : Inhibition of tumor-promoting effects by poricoic acids G and H and other lanostane-type triterpenes and cytotoxic activity of poricoic acids A and G from Poria cocos. J. Nat. Prod. 65, 462 (2002)
DOI
ScienceOn
|
8 |
Mizushina, Y., Tanaka, N., Kitamura, A., Tarnai, K., Ikeda, M., Takemura, M., Sugawara, E, Arai, T., Matsukage, A., Yoshida, S. and Sakaguchi, K. : The inhibitory effect of novel triterpenoid compounds, fomitellic acids, on DNA polymerase beta. Biochem. J. 330, 1325 (1998)
DOI
|
9 |
Tripos Co. Sybyl ver. 6.9.2. Manual (2004)
|
10 |
Kerrigan, J. E. and Pilch, D. S. : A structural model for the ternary cleavable complex formed between human topoisomerase I, DNA, and camptothecin. Biochemistry 40, 9792 (2001)
DOI
ScienceOn
|
11 |
Capranico, G. and Binaschi, M. : DNA sequence selectivity of topoisomerases and topoisomerase poisons. Biochim. Biophys. Acta. 1400, 185 (1998)
DOI
ScienceOn
|
12 |
Laco, G. S., Collins, J. R., Luke, B. T., Kroth, H., Sayer, J. M., Jerina, D. M. and Pommier, Y. : Human topoisomerase I inhibition: docking camptothecin and derivatives into a structure-based active site model. Biochemistry 41, 1428 (2002)
DOI
ScienceOn
|
13 |
Yamashita, Y., Fujii, N., Murakata, C., Ashizawa, T., Okabe, M. and Nakano, H. : Induction of mammalian DNA topoisomerase I mediated DNA cleavage by antitumor indolocarbazole derivatives. Biochemistry 31, 12069 (1992)
DOI
ScienceOn
|
14 |
Giner-Larza, E. M., Manez, S., Giner-Pons, R. M., Carmen Recio, M. and Rios, J. L. : On the anti-inflammatory and anti-phospholipase A(2) activity of extracts from lanostane-rich species. J. Ethnopharmacol. 73, 61 (2000)
DOI
ScienceOn
|
15 |
Jayaraman, M., Fox, B. M., Hollingshead, M., Kohlhagen, G., Pommier, Y. and Cushman, M. : Synthesis of new dihydroindeno[1,2-c]isoquinoline and indenoisoquinolinium chloride topoisomerase I inhibitors having high in vivo anticancer activity in the hollow fiber animal model. J. Med. Chem. 45, 242 (2002).
DOI
ScienceOn
|
16 |
Li, T. K., Bathory, E., LaVoie, E. J., Srinivasan, A. R., Olson, W. K., Sauers, R. R., Liu, L. F. and Pilch, D. S. : Human topoisomerase I poisoning by protoberberines: potential roles for both drug-DNA and drug-enzyme interactions. Biochemistry 39, 7107 (2000)
DOI
ScienceOn
|
17 |
Krogh, B. O. and Shuman, S. : Catalytic mechanism of DNA topoisomerase lB. Mol. Cell 5, 1035 (2000)
DOI
ScienceOn
|
18 |
Mizushina, Y., Akihisa, T., Ukiya, M., Murakami, C., Kuriyama, I., Xu, X., Yoshida, H. and Sakaguchi, K. : A novel DNA topoisomerase inhibitor: dehydroebriconic acid, one of the lanostane-type triterpene acids from Poria cocos. Cancer Sci. 95, 354 (2004)
DOI
ScienceOn
|
19 |
Staker, B. L., Feese, M. D., Cushman, M., Pommier, Y., Zembower, D., Stewart, L. and Burgin, A. B. : Structures of three classes of anticancer agents bound to the human topoisomerase I-DNA covalent complex. J. Med. Chem. 48, 2336 (2005)
DOI
ScienceOn
|
20 |
Fan, Y., Weinstein, J. N., Kohn, K. W., Shi, L. M. and Pommier, Y. : Molecular modeling studies of the DNA-topoisomerase I ternary cleavable complex with camptothecin. J. Med. Chem. 41, 2216 (1998)
DOI
ScienceOn
|
21 |
Tai, T. S. T., Kikuchi, T., Tezka, Y and Akahori, A. : Triterpenes from the surface of Poria cocos. Phytochemistry 35, 1165-9 (1995)
|
22 |
Chrencik, J. E., Staker, B. L., Burgin, A. B., Pourquier, P., Pommier, Y., Stewart, L. and Redinbo, M. R. : Mechanisms of camptothecin resistance by human topoisomerase I mutations. J. Mol. Biol. 339, 773 (2004)
DOI
ScienceOn
|
23 |
Redinbo, M. R., Stewart, L., Kuhn, P., Champoux, J.J. and Hol, W. G. : Crystal structures of human topoisomerase I in covalent and noncovalent complexes with DNA. Science 279, 1504 (1998)
DOI
ScienceOn
|
24 |
Pommier, Y., Pourquier, P., Fan, Y. and Strumberg, D. : Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme. Biochim. Biophys. Acta. 1400, 83 (1998)
DOI
|
25 |
Staker, B. L., Hjerrild, K., Feese, M. D., Behnke, C. A., Burgin, A. B. Jr. and Stewart, L. : The mechanism of topoisomerase I poisoning by a camptothecin analog. Proc. Natl. Acad. Sci. 99, 15387 (2002)
|